Next-Generation Sequencing Market: Market Trends and Market Forecast 2024-2032
The Next-Generation Sequencing (NGS) market is experiencing significant growth, driven by technological advancements and increasing demand for personalized medicine. Valued at USD 8.3 billion in 2023, the market is projected to reach USD 50 billion by 2032, growing at a compound annual growth rate (CAGR) of 22% during the forecast period of 2024-2032.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/3720
Regional Analysis
- North America: This region led the NGS market in 2023, attributed to the presence of major technology companies, robust healthcare infrastructure, and substantial investments in research and development.
- Asia Pacific: Anticipated to exhibit rapid growth due to increasing investments in healthcare infrastructure and expanding research activities. Countries like China and India are emerging as key players with significant advancements in genomic research and technology.
Market Segmentation
- By Product:
- Consumables: Held a significant market share in 2023, driven by frequent use of sample preparation kits essential for research and commercial applications.
- By Technology:
- Targeted Sequencing & Resequencing: A dominant segment in 2023, expected to grow rapidly due to the increasing popularity of whole genome sequencing.
- By Workflow:
- Sequencing: Led the market in 2023, enhancing efficiency through automation of tasks such as tube and microplate management.
- By Application:
- Oncology: Commanded a significant share, with extensive use of NGS for DNA and RNA sequencing, epigenetics studies, and chromosomal abnormality analysis, supporting precision medicine.
- By End User:
- Academic Research: Held the largest market share in 2023, driven by the widespread adoption of NGS technologies in universities and research institutions for genomic studies.
Key Players
- Illumina (NovaSeq Series, MiSeq, NextSeq Series)
- F. Hoffman-La Roche Ltd. (GeneReader, NimbleGen)
- QIAGEN (GeneReader NGS System, QIAseq)
- Thermo Fisher Scientific, Inc. (Ion Proton System, Ion S5 System, Applied Biosystems GeneMapper Software)
- Bio-Rad Laboratories, Inc. (ddPCR (Droplet Digital PCR))
- Oxford Nanopore Technologies (MinION, GridION, PromethION)
- PierianDx (PierianDx Platform)
- Genomatix GmbH (Genomatix Suite)
- DNASTAR, Inc. (Lasergene Genomics Suite)
- Perkin Elmer, Inc. (BioQule NGS System)
- Eurofins GATC Biotech GmbH (GATC Biotech NGS Services)
- BGI (BGISEQ Series)
- PacBio (Sequel II System)
- Agilent Technologies (SureSelect, InfinityLab) and others.
Key Market Insights
- Technological innovations are enhancing sequencing accuracy and reducing costs.
- Growing prevalence of genetic disorders and cancer is increasing the demand for advanced diagnostic tools.
- Strategic collaborations among industry players are fostering market expansion.
- Government initiatives and funding are supporting genomic research and personalized medicine.
Future Scope
The NGS market is poised for substantial expansion, driven by continuous technological advancements and the increasing integration of sequencing technologies into clinical diagnostics and personalized medicine. Emerging applications in fields such as reproductive health, metagenomics, and consumer genomics present new growth opportunities. Additionally, the development of more accurate and cost-effective sequencing platforms is expected to further propel market growth.
Conclusion
The Next-Generation Sequencing market is on a robust growth trajectory, fueled by technological innovations and a rising demand for comprehensive genomic analysis. As NGS becomes increasingly integral to various applications, from oncology to personalized medicine, the market is expected to witness sustained expansion, offering numerous opportunities for stakeholders across the healthcare and research sectors.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian